{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[13,2,13,3],[14,2,14,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910457240603321"]
[null,null,"Titolo",null,"Protecting the frontline in biodefense research [[electronic resource] ] : the Special Immunizations Program / / National Research Council of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academies Press, c2011"]
[null,null,"ISBN",null,"1-283-21341-9"]
[{"$nulls":4},"9786613213419"]
[{"$nulls":4},"0-309-20925-0"]
[null,null,"Descrizione fisica",null,"1 online resource (183 p.)"]
[null,null,"Disciplina",null,"358.38"]
[null,null,"Soggetti",null,"Biological warfare - Research - Safety measures"]
[{"$nulls":4},"Biological warfare - Research - Health aspects"]
[{"$nulls":4},"Vaccines - United States"]
[{"$nulls":4},"Medicine, Military - United States"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Selected Agents, Board on Life Sciences, Division on Earth and Life Studies.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"Front Matter\"\"; \"\"Acknowledgments\"\"; \"\"Contents\"\"; \"\"Summary\"\"; \"\"1 Introduction\"\"; \"\"2 History of the Special Immunizations Program and Lessons Learned from Occupational Immunization Against Hazardous Pathogens\"\"; \"\"3 The U.S. Medical Countermeasures Enterprise and Recent Reviews and Current Operation of the Special Immunizations Program\"\"; \"\"4 Regulations and Other Guidance Pertaining to the Development and Use of Vaccines in the Special Immunizations Program\"\"; \"\"5 New Vaccine Development and the Future Needs of the Special Immunizations Program\"\""]
[{"$nulls":4},"\"\"6 Potential Options for the Special Immunizations Program and for Personnel Immunization\"\"\"\"7 Conclusions and Recommendations\"\"; \"\"References\"\"; \"\"Appendixes\"\"; \"\"Appendix A: Committee Member Biographies\"\"; \"\"Appendix B: Abbreviations and Acronyms\"\"; \"\"Appendix C: Glossary\"\""]
[null,null,null,"Sommario/riassunto","\"The U.S. Army's Special Immunizations Program is an important component of an overall biosafety program for laboratory workers at risk of exposure to hazardous pathogens. The program provides "]
[{"$nulls":4},"immunizations to scientists, laboratory technicians and other support staff who work with certain hazardous pathogens and toxins. Although first established to serve military personnel, the program was expanded through a cost-sharing agreement in 2004 to include other government and civilian workers, reflecting the expansion in biodefense research in recent years. Protecting the Frontline in Biodefense Research examines issues related to the expansion of the Special Immunizations Program, considering the regulatory frameworks under which the vaccines are administered, how additional vaccines might be considered for inclusion in the Program, and factors that might influence the development and manufacturing of vaccines for the Special Immunizations Program.\"--Publisher's description."]